A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses

ABSTRACT:

SUBMITTER: Smith K 

PROVIDER: S-EPMC10644866 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature